Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136519) titled 'Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Affiliated Hospital of Guangdong Medical University
Condition:
Nasopharyngeal Carcinoma (NPC)
Intervention:
Drug: Toripalimab
Dietary Supplement: Omega-3
Radiation: radiotherapy
Drug: Paclitaxel (albumin bound)
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: August 22, 2025
Target...